Applying Available Data and Disease Management Programs to Optimize Gout Treatment and Outcomes
Applying Available Data and Disease Management Programs to Optimize Gout Treatment and Outcomes
On-Demand Webcast
Presenters/Q&A Cohosts
William J. Cardarelli, PharmD
Director of Pharmacy
Atrius Health
Harvard Vanguard Medical Associates
Watertown, Massachusetts
Michael H. Pillinger, MD
Associate Professor of Medicine
NYU School of Medicine
New York, New York
Intended Learners
This activity is designed for managed markets physicians and pharmacists, pharmacy directors, medical directors, formulary decision makers, and other managed care professionals.
Learning Objectives
After completing this activity, participants should be able to:
- Quantify the economic burden of gout, including direct and indirect costs of suboptimally managed disease
- Discuss the therapeutic, regulatory, and pharmacoeconomic issues associated with treatments for acute gout flares
- Describe treat-to-target strategies for management of hyperuricemia
- Outline demographic and disease-related factors that impact patient adherence to therapy
- Apply disease management programs in therapeutic areas with similar adherence challenges to the development of a gout-specific program
Activity Overview
This on-demand webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participants complete the educational activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release Date: January 16, 2012
Expiration Date: January 16, 2013
Estimated time to complete: 1 hour
There is no fee associated with this activity.
This educational activity is a knowledge-based activity.
For questions regarding this educational activity, please call 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME
NACCME designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE
This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-11-074-H01-P).
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation Services, NACCME, may be made for a second level of review.
Independent Clinical Reviewer: Robert T. Keenan, MD, MPH, Assistant Professor of Medicine, Medical Director, Center for Advanced Therapeutics, DUHS, Duke University School of Medicine, Durham, North Carolina
Planning Committee
The planning committee comprises of William J. Cardarelli, PharmD; Robert T. Keenan, MD, MPH, Michael H. Pillinger, MD; Edward Jackson, MD, Mary Johnson, Mike Kearney, Nick Lombardi, Kristen Petitto, Randy Robbin, Lynn Rubin, John Savage, and Jessica Steuerman, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Cardarelli, Dr. Keenan, and Dr. Pillinger have disclosed no relevant financial relationships with any commercial interests.
Dr. Jackson, Ms. Johnson, Mr. Kearney, Ms. Petitto, Mr. Robbin, Ms. Rubin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.
Mr. Lombardi: Stock shareholder-Inspire Pharmaceuticals, Inc., ViroPharma, Inc., Vertex Pharmaceuticals
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
No off-label/unapproved uses of drugs and/or devices will be discussed in the activity materials.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2012 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
Grant Support
Supported by an educational grant from URL Pharma.
